Product Information

YASMIN 28 TABLET is a brand product labeled by Bayer HealthCare Pharmaceuticals Inc., priced at $4.3984 per EA under NDC 50419040203. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on May 11, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the drospirenone and ethinyl estradiol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

YASMIN 28 TABLET

drospirenone and ethinyl estradiol
$4.3984per EA
High Outlier

NDC

50419040203

Classification

Brand

Dosage Form

KIT

Effective Date

8/19/2026

Approval Type

New Drug (NDA)

FDA Application

NDA021098

FDA Approved

5/11/2001

TE Code

AB

On Market Since

5/11/2001

Price Statistics

The NADAC for YASMIN 28 TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 63.9%. The table below summarizes its recorded NADAC range and movement.

Current price$4.3984 per EA
All-time high$4.4159 (Oct 11, 2023)
All-time low$2.6689 (Aug 20, 2014)
52-week high$4.4146
52-week low$4.3984
Median price$4.2737
Average price$3.9440
Largest weekly change+9.9% (Feb 18, 2015)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-0.0%

1M

-0.0%

3M

-0.0%

6M

-0.1%

1Y

-0.1%

3Y

-0.4%

5Y

+2.0%

All

+63.9%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of YASMIN 28 TABLET?

The current National Average Drug Acquisition Cost (NADAC) for YASMIN 28 TABLET, manufactured by Bayer HealthCare Pharmaceuticals Inc., is $4.3984 per EA (NDC 50419040203), effective Aug 19, 2026.

How has the price of YASMIN 28 TABLET changed over time?

Over the history we have for it, the NADAC for YASMIN 28 TABLET has risen 63.9%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for YASMIN 28 TABLET?

Since Nov 28, 2013, the NADAC for YASMIN 28 TABLET has ranged from a low of $2.6689 (Aug 20, 2014) to a high of $4.4159 (Oct 11, 2023), with a median of $4.2737 per EA.

Are there cheaper alternatives to YASMIN 28 TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DROSPIRENONE-EE 3-0.03 MG TAB, is $0.1492 per EA — about 97% below YASMIN 28 TABLET.

Who manufactures YASMIN 28 TABLET?

YASMIN 28 TABLET (NDC 50419040203) is labeled by Bayer HealthCare Pharmaceuticals Inc., and CMS classifies it as a brand product.